GB202013716D0 - Antiviral and regenerative medicament - Google Patents

Antiviral and regenerative medicament

Info

Publication number
GB202013716D0
GB202013716D0 GBGB2013716.2A GB202013716A GB202013716D0 GB 202013716 D0 GB202013716 D0 GB 202013716D0 GB 202013716 A GB202013716 A GB 202013716A GB 202013716 D0 GB202013716 D0 GB 202013716D0
Authority
GB
United Kingdom
Prior art keywords
antiviral
regenerative
medicament
regenerative medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2013716.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arcadix Ltd
Kasparova Evgeniya Arcadievna
Wales Elizaveta Arcadievna
Original Assignee
Arcadix Ltd
Kasparova Evgeniya Arcadievna
Wales Elizaveta Arcadievna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcadix Ltd, Kasparova Evgeniya Arcadievna, Wales Elizaveta Arcadievna filed Critical Arcadix Ltd
Priority to GBGB2013716.2A priority Critical patent/GB202013716D0/en
Publication of GB202013716D0 publication Critical patent/GB202013716D0/en
Ceased legal-status Critical Current

Links

GBGB2013716.2A 2020-09-01 2020-09-01 Antiviral and regenerative medicament Ceased GB202013716D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2013716.2A GB202013716D0 (en) 2020-09-01 2020-09-01 Antiviral and regenerative medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2013716.2A GB202013716D0 (en) 2020-09-01 2020-09-01 Antiviral and regenerative medicament

Publications (1)

Publication Number Publication Date
GB202013716D0 true GB202013716D0 (en) 2020-10-14

Family

ID=72749624

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2013716.2A Ceased GB202013716D0 (en) 2020-09-01 2020-09-01 Antiviral and regenerative medicament

Country Status (1)

Country Link
GB (1) GB202013716D0 (en)

Similar Documents

Publication Publication Date Title
MX2014011771A (en) Tissue thickness compensator comprising a plurality of medicaments.
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
IL233874A0 (en) Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
WO2015057087A3 (en) Headgear
IL285148A (en) Bi-ligand drug conjugate and use thereof
IL289096A (en) Parenteral lysophosphatidylcholine formulations such as lpc-dha, lpc-epa and their use in therapy
GB201802895D0 (en) Laminate structure and wearable article
EP4121043A4 (en) Mdm2 degraders and uses thereof
EP4185300A4 (en) Antiviral prodrugs, pharmaceutical formulations, and methods
IL312330A (en) Tyk2 degraders and uses thereof
GB202019475D0 (en) Therapeutic compounds and their use
HUE055833T2 (en) Antiviral precursor drug nucleoside cyclophosphate compound and use thereof
WO2015028875A8 (en) Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
MA40496A (en) Capsaicinoids and uses thereof as medicaments
GB202013716D0 (en) Antiviral and regenerative medicament
IL291543A (en) Therapeutic formulations and uses thereof
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
EP4162029A4 (en) Human nsclc cell lines and use thereof
EP4140480A4 (en) Drug combination and use thereof
EP4144360A4 (en) Sars-cov-2 antiviral drug antiprovir
GB202003057D0 (en) Medicament and use thereof
GB202005793D0 (en) Antiviral Medications
GB202009054D0 (en) Blister pack and inhaler comprising the same
GB202003212D0 (en) Antiviral therapy
IL311151A (en) Antiviral structurally-stapled sars-cov-2 peptide- cholesterol conjugates and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)